Biogen and Invitae Announce Availability of Rapid Results in Genetic Testing Program for Spinal Muscular Atrophy (SMA) to Improve Speed of Diagnosis for Patients August 20, 2019 - NASDAQ Companies 0 » View More News for August 20, 2019